Activation of human Kupffer cells by thymostimulin (TP-1) to produce cytotoxicity against human hepatocellular cancer

Annals of Surgical Oncology

Volumn 4, Issue 2, 1997, Pages 149-155

  Balch, Glen ^a   Izzo, Francesco ^a   Chiao, Paul ^a   Klostergaard, Jim ^a   Curley, Steven A ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Hepatocellular cancer; Kupffer cells; Thymostimulin

Indexed keywords

IMMUNOLOGICAL ADJUVANT; MONOKINE; THYMOSTIMULIN; THYMUS EXTRACT;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CYTOTOXICITY; DRUG EFFECT; HUMAN; IMMUNOLOGY; KUPFFER CELL; LIVER CELL CARCINOMA; LIVER TUMOR; PATHOLOGY;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; KUPFFER CELLS; LIVER NEOPLASMS, EXPERIMENTAL; MONOKINES; THYMUS EXTRACTS;

EID: 0031087081     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02303798     Document Type: Article

References (20)

1. Curley SA, Levin B, Rich TA. Liver and bile ducts. In: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE, eds. Clinical oncology. New York: Churchill Livingstone, 1995:1305-72.
2. Rustgi V. Epidemiology of hepatocellular cancer. Ann Intern Med 1989;108:390-7.
3. Shoham J, Theodor E, Brenner HJ, Goldman B, Lusky A, Chaitchick S. Enhancement of the immune system of chemotherapy-treated cancer patients by simultaneous treatment with thymic extract, TP-1. Cancer Immunol Immunother 1980;9:173-80.
4. Klein AS, Fixler R, Shoham J. Antiviral activity of a thymic factor in experimental viral infections. J Immunol 1984;132:3159-63.
5. Palmieri G, Gravina A, Frasci G, Montesarchio V, Leo L, Bianco AR. Thymostimulin treatment of hepatitis and cirrhosis. Proceedings of the First International Conference on Hepatobiliary Tumors. Rome: Monduzzi Editore, 1992;1:51.
6. Mustacchi G, Pevise L, Milani S, et al. High-dose folinic acid (FA) and fluorouracil (FU) plus or minus thymostimulin (TS) for treatment of metastatic colorectal cancer: results of a randomized multicenter clinical trial. Anticancer Res 1994;14:617-20.
7. Tanaka H, Hiyama T, Tsukuma H, et al. Cumulative risk of hepatocellular carcinoma in hepatitis C virus carriers: statistical estimations from cross-section data. Jpn J Cancer Res 1994;85:485-90.
8. Ikeda K, Saitoh S, Koida I, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993;18:47-53.
9. Curley SA, Izzo F, Gallipoli A, De Bellis M, Cremona F, Parisi V. Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular cancer. Ann Surg 1995;222:375-83.
10. Palmieri G, Cimmino L, Gravina A, Topa M, Budillon G, Bianco AR. Thymostimulin treatment of hepatocellular carcinoma: preliminary data. Proceedings of the First International Conference on Hepatobiliary Tumors. Rome: Monduzzi Editore, 1992;1:52.
11. Lanford RE, Carey KD, Estlack LE, Smith GC, Hay RV. Analysis of plasma protein and lipoprotein synthesis in long-term primary cultures of baboon hepatocytes maintained in serum-free medium. In Vitro Cell Dev Biol 1989;25:174-82.
12. White AL, Rainwater DL, Lanford RE. Intracellular maturation of apolipoprotein[a] and assembly of lipoprotein[a] in primary baboon hepatocytes. J Lipid Res 1993;34:509-17.
13. Strom SG, Jirtle RL, Jons RS, et al. Isolation, culture, and transplantation of human hepatocytes. J Natl Cancer Inst 1982;68:771-8.
14. Heuff G, Steenbergen JJE, Van de Loosdrecht AA, et al. Isolation of cytotoxic Kupffer cells by a modified enzymatic assay: a methodological study. J Immunol Methods 1993;159:115-23.
15. Shoham J, Cohen M. Thymic hormonal activity on human peripheral blood lymphocytes, in vitro. V. Effect on induction of lymphocytotoxicity. Int J Immunopharmacol 1983;6:523-32.
16. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tertrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 1987;47:943-6.
17. Falchetti R, Bergesi G, Eshkol A, Cafiero C, Adorini L, Caprino L. Pharmacological and biological properties of a calf thymus extract (TP-1). Drugs Exp Clin Res 1977;3:39-47.
18. Shoham J, Eshel I, Aboud M, Salzberg S. Thymic hormonal activity on human peripheral blood lymphocytes in vitro. J Immunol 1980;125:54-8.
19. Aiuti F, Papetti C. Pharmacodynamics of thymic hormones. In: Byrom NA, Hobbs JR, eds. Thymic factor therapy. New York: Academic, 1990:33-43.
20. Palmisano L, Biglino A, Panichi G, et al. Combined chemoimmunotherapy (AZT-thymostimulin) in HIV positive patients: a multicenter, randomized, controlled study. Presented at IXth International Conference on AIDS, Berlin, June 7-11, 1993.